Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lloyd

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
BMJ Open|November 13, 2024
'Blue-lighting' seizure-related needs in care homes: a retrospective analysis of ambulance call-outs for seizures in North West England (2014-2021), their management and costs, with community comparisonsAdam J Noble, Steven Lane, Peter Lloyd, et al.
Journal of Clinical Pharmacology|November 20, 2014
Safety and tolerability of serelaxin, a recombinant human relaxin-2 in development for the treatment of acute heart failure, in healthy Japanese volunteers and a comparison of pharmacokinetics and pharmacodynamics in healthy Japanese and Caucasian populationsMarion Dahlke, Dik Ng, Masayuki Yamaguchi, et al.
The Journal of Organic Chemistry|July 1, 2006
Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification schemeMichelle Lee, Peter Lloyd, Xiyun Zhang, et al.
Bioanalysis|December 23, 2014
Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibodyWai Siang Law, Jean-Christophe Genin, Christian Miess, et al.
Journal for Immunotherapy of Cancer|January 21, 2022
Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primateRosemina Merchant, Carole Galligan, Manjunatha Ankathatti Munegowda, et al.
Lancet (London, England)|August 25, 2025
Upholding medical ethics: a letter to the Israeli Medical AssociationLeon Geffen, Mitch Besser, Eric Goemaere, et al.
Lancet (London, England)|December 4, 2014
Macroeconomic implications of population ageing and selected policy responsesDavid E Bloom, Somnath Chatterji, Paul Kowal, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 14, 2001
Altered hemodynamics controls matrix metalloproteinase activity and tenascin-C expression in neonatal pig lungPeter Lloyd Jones, Rene Chapados, H Scott Baldwin, et al.
Journal of Clinical Pharmacology|January 30, 2004
Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusionBin Peng, Catherine Dutreix, Gunther Mehring, et al.
Circulation|June 2, 2005
Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertensionD Dunbar Ivy, Ivan F McMurtry, Kelley Colvin, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
BMJ Open|November 13, 2024
'Blue-lighting' seizure-related needs in care homes: a retrospective analysis of ambulance call-outs for seizures in North West England (2014-2021), their management and costs, with community comparisonsAdam J Noble, Steven Lane, Peter Lloyd, et al.
Journal of Clinical Pharmacology|November 20, 2014
Safety and tolerability of serelaxin, a recombinant human relaxin-2 in development for the treatment of acute heart failure, in healthy Japanese volunteers and a comparison of pharmacokinetics and pharmacodynamics in healthy Japanese and Caucasian populationsMarion Dahlke, Dik Ng, Masayuki Yamaguchi, et al.
The Journal of Organic Chemistry|July 1, 2006
Shapes of antibody binding sites: qualitative and quantitative analyses based on a geomorphic classification schemeMichelle Lee, Peter Lloyd, Xiyun Zhang, et al.
Bioanalysis|December 23, 2014
Use of generic LC-MS/MS assays to characterize atypical PK profile of a biotherapeutic monoclonal antibodyWai Siang Law, Jean-Christophe Genin, Christian Miess, et al.
Journal for Immunotherapy of Cancer|January 21, 2022
Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primateRosemina Merchant, Carole Galligan, Manjunatha Ankathatti Munegowda, et al.
Lancet (London, England)|August 25, 2025
Upholding medical ethics: a letter to the Israeli Medical AssociationLeon Geffen, Mitch Besser, Eric Goemaere, et al.
Lancet (London, England)|December 4, 2014
Macroeconomic implications of population ageing and selected policy responsesDavid E Bloom, Somnath Chatterji, Paul Kowal, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 14, 2001
Altered hemodynamics controls matrix metalloproteinase activity and tenascin-C expression in neonatal pig lungPeter Lloyd Jones, Rene Chapados, H Scott Baldwin, et al.
Journal of Clinical Pharmacology|January 30, 2004
Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusionBin Peng, Catherine Dutreix, Gunther Mehring, et al.
Circulation|June 2, 2005
Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertensionD Dunbar Ivy, Ivan F McMurtry, Kelley Colvin, et al.
Pageof 12